GSK (BSP:G1SK34) 3-Year EPS without NRI Growth Rate

: 15.00% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

GSK's EPS without NRI for the three months ended in Dec. 2023 was R$1.19.

During the past 12 months, GSK's average EPS without NRI Growth Rate was 14.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 15.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 2.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of GSK was 126.60% per year. The lowest was -32.90% per year. And the median was 5.30% per year.

Competitive Comparison

For the Drug Manufacturers - General subindustry, GSK's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GSK 3-Year EPS without NRI Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, GSK's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where GSK's 3-Year EPS without NRI Growth Rate falls into.

GSK 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

GSK (BSP:G1SK34) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

GSK 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of GSK's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK (BSP:G1SK34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BSP:G1SK34) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany GSK:Argentina

Address

980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK (BSP:G1SK34) Headlines

No Headlines